Even with its December decline, Nvidia shares ended 2024 up more than 150%. Analysts have remained bullish on the stock, estimating shares will rise to roughly $173 over the next year from their ...
Research analysts at StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage ...
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts ...